Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from PACS Group Inc ( (PACS) ) is now available.
On May 29, 2025, PACS Group Inc. and its subsidiary, PACS Holdings, LLC, amended their credit agreement with Truist Bank, extending the deadline for delivering audited financial statements for the fiscal year ended December 31, 2024. The amendment also requires maintaining a minimum of $100 million in unrestricted cash and investments until the financial statements are delivered. The company has faced delays in filing its financial reports due to an ongoing independent investigation, resulting in a notice of noncompliance from the NYSE. The NYSE has granted PACS Group an additional trading period until September 2, 2025, to regain compliance, with a maximum cure period expiring on November 19, 2025.
The most recent analyst rating on (PACS) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on PACS Group Inc stock, see the PACS Stock Forecast page.
Spark’s Take on PACS Stock
According to Spark, TipRanks’ AI Analyst, PACS is a Neutral.
The overall score for PACS Group Inc is moderate due to strong revenue growth counterbalanced by high financial leverage and negative technical indicators. Regulatory risks from noncompliance with NYSE requirements further impact the score. Limited valuation data and lack of earnings call insights add to the uncertainty surrounding the stock.
To see Spark’s full report on PACS stock, click here.
More about PACS Group Inc
Average Trading Volume: 500,167
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.54B
See more data about PACS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue